A Pilot Study of the Mechanism of Synergism Between Fluticasone (FP) and Salmeterol in Preventing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fluticasone propionate; Salmeterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 05 Aug 2014 Biomarkers information updated
- 13 Oct 2009 Actual patient number (15) added as reported by ClinicalTrials.gov.
- 13 Oct 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.